NCT00295919 2026-04-14
N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Phase 1 Completed
New Approaches to Neuroblastoma Therapy Consortium
Montefiore Medical Center
University of Chicago
Roswell Park Cancer Institute
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal